Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04445701. IPD Sharing: NO. Countries: 1. Publications: 1.
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
ClinicalTrials.gov study NCT00443235. IPD Sharing: Not stated. Countries: 1. Publications: 35.
A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03234972. IPD Sharing: Not stated. Countries: 2. Publications: 2.
BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
ClinicalTrials.gov study NCT03502577. IPD Sharing: NO. Countries: 1. Publications: 2.
Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00334932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT02659293. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
ClinicalTrials.gov study NCT03815383. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
ClinicalTrials.gov study NCT04093596. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Multiple Myeloma - oncogeriatrics
Open the record for dataset details and reuse information.
UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma
ClinicalTrials.gov study NCT01884688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01632150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
ClinicalTrials.gov study NCT04816526. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma
ClinicalTrials.gov study NCT05841550. IPD Sharing: YES. Countries: 1. Publications: 0.
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02633059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02928029. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT05393804. IPD Sharing: YES. Countries: 1. Publications: 0.
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05922501. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01001442. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02807454. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury
ClinicalTrials.gov study NCT05429515. IPD Sharing: NO. Countries: 0. Publications: 11.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.